G. Steven Burrill, 63, has served as a member of our board of directors since August 2004, and as Chairman of the Board since November 2004. Mr. Burrill is the founder and CEO of Burrill & Company, a San Francisco-based life sciences merchant bank. Prior to founding Burrill & Craves in 1994 and Burrill & Company in 1997, Mr. Burrill spent 28 years with Ernst & Young, directing and coordinating the firm’s services to clients in the life sciences, high technology and manufacturing industries worldwide. Mr. Burrill currently serves as a member of the board of directors of DepoMed, Inc., a public biotechnology company, where he is chairman of both the audit committee and the compensation committee, and Targacept, Inc. Mr. Burrill is a member of the board of directors of Catalyst Biosciences, Inc., Intranasal Therapeutics, Inc., Phytomedics, Inc., ProteoGenix, Inc., Proventys, Inc., and XDx Inc., all privately held biotechnology companies. Mr. Burrill received his B.B.A. from the University of Wisconsin-Madison. |